Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 13 CAD Market Closed
Market Cap: 149.2m CAD

Relative Value

The Relative Value of one RX stock under the Base Case scenario is hidden CAD. Compared to the current market price of 13 CAD, Biosyent Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
33
Median 3Y
3.3
Median 5Y
3.4
Industry
2.7
Forward
3.3
vs History
44
vs Industry
28
Median 3Y
16.3
Median 5Y
16.6
Industry
21.6
Forward
16.9
vs History
47
vs Industry
29
Median 3Y
17.6
Median 5Y
17.8
Industry
16.9
vs History
52
vs Industry
25
Median 3Y
18.3
Median 5Y
18.9
Industry
22.9
vs History
3
vs Industry
20
Median 3Y
3.1
Median 5Y
3.3
Industry
2.3
vs History
33
vs Industry
36
Median 3Y
2.6
Median 5Y
2.7
Industry
3
Forward
2.8
vs History
28
vs Industry
49
Median 3Y
3.3
Median 5Y
3.4
Industry
5.6
vs History
34
vs Industry
30
Median 3Y
10
Median 5Y
10
Industry
13.4
Forward
9.8
vs History
33
vs Industry
33
Median 3Y
10.7
Median 5Y
10.8
Industry
16.7
vs History
33
vs Industry
33
Median 3Y
12.9
Median 5Y
13.3
Industry
16.1
vs History
33
vs Industry
28
Median 3Y
13.3
Median 5Y
13.3
Industry
18.9
vs History
63
vs Industry
15
Median 3Y
6.2
Median 5Y
8.2
Industry
2

Multiples Across Competitors

RX Competitors Multiples
Biosyent Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Biosyent Inc
XTSX:RX
146.4m CAD 3.5 17 10.6 11.4
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
276.8B CHF 4.5 29.3 12.5 14.5
UK
AstraZeneca PLC
LSE:AZN
218.6B GBP 5 31.2 108.4 158.7
CH
Novartis AG
SIX:NOVN
221.9B CHF 4.9 19.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.3 16.1 11.2 13
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
CA
Biosyent Inc
XTSX:RX
Average P/E: 24
17
15%
1.1
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.3
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.2
37%
0.8
CH
Novartis AG
SIX:NOVN
19.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.1
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Biosyent Inc
XTSX:RX
Average EV/EBITDA: 400.9
10.6
14%
0.8
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.5
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Biosyent Inc
XTSX:RX
Average EV/EBIT: 1 713.4
11.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.7
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5